Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2026-01-21 @ 6:53 AM
Study NCT ID:
NCT02837757
Status:
TERMINATED
Last Update Posted:
2022-05-16
First Post:
2016-07-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Everolimus Modulation of Anti-tumor T CD4 Immune Responses
Sponsor:
Centre Hospitalier Universitaire de Besancon
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Renal Cancer | View |
Keywords: